CardioLogs ECG Analysis Platform vs Zio AT ECG Monitoring System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 70/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by CardioLogs (acquired by Philips in 2021)
VS
by iRhythm Technologies, Inc.

AI Verdict

While both tools leverage AI for ECG analysis to detect arrhythmias, their operational models differ. Tool A is a versatile platform designed to analyze ECG data from various cardiac monitoring devices, offering broad compatibility. In contrast, Tool B is an integrated system centered around its proprietary wearable patch, providing a complete solution for continuous, long-term ECG monitoring.

Choose CardioLogs ECG Analysis Platform if…

Choose CardioLogs ECG Analysis Platform if your practice utilizes a diverse range of cardiac monitoring devices and requires a centralized, AI-powered solution for rapid and efficient analysis of ECG data from multiple sources. This platform is ideal for integrating existing hardware and streamlining arrhythmia detection across various patient monitoring workflows.

View CardioLogs ECG Analysis Platform →

Choose Zio AT ECG Monitoring System if…

Choose Zio AT ECG Monitoring System if you need a comprehensive, integrated mobile cardiac telemetry (MCT) service for continuous, long-term arrhythmia detection using a dedicated wearable patch. This system is best suited for identifying intermittent or asymptomatic cardiac events over an extended period with real-time data transmission and a complete patient and clinician management ecosystem.

View Zio AT ECG Monitoring System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CardioLogs ECG Analysis Platform Zio AT ECG Monitoring System
Pricing Unknown Contact for pricing
Deployment Cloud-based Cloud-based (data analytics and clinician portal)
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

CardioLogs ECG Analysis Platform

CardioLogs offers a cloud-based platform with multi-device compatibility, including smartwatches and Holter monitors, and integrates with EHR systems, streamlining existing clinical workflows. Its user-friendly interface and ability to reduce analysis time by approximately 42% enhance efficiency for clinicians. While Zio AT provides a convenient, patient-centric wearable, CardioLogs' vendor neutrality and broader integration capabilities offer greater flexibility for diverse clinical settings.

Clinical Value

CardioLogs ECG Analysis Platform

Both tools are FDA-cleared and leverage AI for arrhythmia detection, demonstrating strong clinical value. CardioLogs, with its deep neural network, has shown to significantly reduce false positives and analysis time, and notably outperforms consumer smartwatch ECG algorithms in detecting atrial arrhythmias by increasing sensitivity and reducing inconclusive readings. While Zio AT offers high diagnostic yield and physician agreement for long-term continuous monitoring, CardioLogs' ability to enhance the accuracy of diverse ECG data sources, including widely used consumer wearables, provides a broader clinical utility.

Pricing & Value

CardioLogs ECG Analysis Platform

Both tools require contacting sales for pricing, indicating a lack of public transparency. However, CardioLogs explicitly states a 'pay per ECG regardless of the number of users' model, which offers a clear and predictable cost structure based on usage. Zio AT's description of 'service fees for monitoring and analysis' is less specific, making it harder to anticipate costs.

Enterprise Readiness

CardioLogs ECG Analysis Platform

Both are FDA-cleared, HIPAA compliant, and cloud-based. However, CardioLogs' acquisition by Philips significantly enhances its enterprise readiness, benefiting from Philips' established global presence, robust IT infrastructure, and comprehensive interoperability solutions like IntelliBridge Enterprise for seamless EHR integration. CardioLogs also explicitly mentions ISO/IEC 27001 certified AWS servers for secure hosting.

Innovation

CardioLogs ECG Analysis Platform

Both tools demonstrate innovation in cardiac AI. Zio AT offers an innovative integrated wearable for long-term continuous monitoring with high patient compliance. However, CardioLogs' innovation in developing a vendor-agnostic deep learning AI platform that can analyze ECG data from a wide array of devices, including consumer smartwatches, and significantly improve their diagnostic accuracy, represents a broader and more adaptable approach to leveraging diverse data sources in the evolving healthcare landscape.

Support & Docs

CardioLogs ECG Analysis Platform

As a Philips solution, CardioLogs benefits from Philips' extensive global support infrastructure, including a customer service center, technical support, and a comprehensive online Customer Services Portal for managing service requests. It also explicitly mentions 24/7 customer support and training. While Zio AT provides customer care contact and app-based resources for clinicians and patients, the breadth of support channels and documented resources appears more extensive for CardioLogs through Philips.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CardioLogs ECG Analysis Platform Zio AT ECG Monitoring System
Company Cardiologs Technologies (now part of Philips) iRhythm Technologies, Inc.
AI-Powered Analysis AI-Powered ECG Analysis (Deep Neural Networks) FDA-cleared deep-learned AI algorithm (ZEUS System) for arrhythmia detection
Monitoring Method / Device Compatibility Multi-Device Compatibility (Holter, smartwatches, ECG patches) Wearable Zio AT patch for continuous ECG recording
Maximum Monitoring Duration Not specified Continuous, uninterrupted ECG recording for up to 14 days
EHR Integration Integration with EHR Systems Not specified
Reporting Customizable Reports Comprehensive end-of-wear reports for clinicians

Videos

Demos, reviews, and walkthroughs featuring CardioLogs ECG Analysis Platform and Zio AT ECG Monitoring System.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

CardioLogs ECG Analysis Platform is designed to analyze ECG data from various cardiac monitoring devices, including Holter monitors, smartwatches, and ECG patches. In contrast, the Zio AT ECG Monitoring System exclusively uses data from its proprietary wearable Zio AT patch for continuous ECG recording.
CardioLogs is an AI-powered cloud-based platform that provides rapid and accurate analysis of ECG data. The Zio AT system, on the other hand, is a comprehensive wearable mobile cardiac telemetry (MCT) service that includes its own device for continuous monitoring, real-time data transmission, AI-powered analysis, and detailed reporting.
The CardioLogs platform analyzes data from various devices, which may have different monitoring durations, but it does not specify a maximum continuous monitoring duration for its own offering. The Zio AT system, however, provides continuous, uninterrupted ECG recording for up to 14 days with its wearable patch.
CardioLogs ECG Analysis Platform is designed to support Cardiology, Emergency Medicine, and Internal Medicine. The Zio AT ECG Monitoring System is primarily focused on Cardiology.
Yes, CardioLogs features real-time monitoring and analysis of ECG data. Zio AT also offers real-time capabilities through its wireless gateway for data transmission from the wearable patch.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.